rss
Qual Health Care 9:232-237 doi:10.1136/qhc.9.4.232
  • Paper

What is a prescribing error?

  1. B Dean, director *
  1. Academic Pharmacy Unit, Hammersmith Hospitals NHS Trust, London W12 0HS
  1. N Barber, professor of the practice of pharmacy
  1. Centre for Practice and Policy, The School of Pharmacy, University of London, London WC1N 1AX
  1. M Schachter, senior lecturer and honorary consultant physician
  1. Department of Clinical Pharmacology, Imperial College School of Medicine, St Mary's Hospital, London W2 1NY
  1. Dr B Dean bryony{at}cua.ulsop.ac.uk
  • Accepted 3 October 2000

Abstract

Objective—To develop a practitioner led definition of a prescribing error for use in quantitative studies of their incidence.

Design—Two stage Delphi technique.

Subjects—A panel of 34 UK judges, which included physicians, surgeons, pharmacists, nurses and risk managers.

Main outcome measures—The extent to which judges agreed with a general definition of a prescribing error, and the extent to which they agreed that each of 42 scenarios represented a prescribing error.

Results—Responses were obtained from 30 (88%) of 34 judges in the first Delphi round, and from 26 (87%) of 30 in the second round. The general definition of a prescribing error was accepted. The panel reached consensus that 24 of the 42 scenarios should be included as prescribing errors and that five should be excluded. In general, transcription errors, failure to communicate essential information, and the use of drugs or doses inappropriate for the individual patient were considered prescribing errors; deviations from policies or guidelines were not.

Conclusions—Health care professionals are in broad agreement about the types of events that should be included and excluded as prescribing errors. A general definition of a prescribing error has been developed, together with more detailed guidance regarding the types of events that should be included. This definition allows the comparison of prescribing error rates among different prescribing systems and different hospitals, and is suitable for use in both research and clinical governance initiatives.

(Quality in Health Care 2000;9:232–237)

Footnotes

  • * At the time of this study Bryony Dean was a Research Pharmacist at the Centre for Practice and Policy, The School of Pharmacy, University of London, London WC1N 1AX.

Free sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BMJ Quality & Safety.
View free sample issue >>

Email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

 

Navigate This Article